A study to evaluate the efficacy and safety of reslizumab in patients with eosinophilic asthma

Aún no traducido Aún no traducido
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2011
Cargando información sobre las referencias
The primary objective of this study is to determine whether reslizumab is more effective than placebo in reducing the number of clinical asthma exacerbations (CAEs) in patients with eosinophilic asthma.
Epistemonikos ID: af2c4e9f68efd1992558df6ec306d4c4e591560c
First added on: Sep 28, 2017